Drug Catalog - Product Detail
HYDROCORTISONE CRM CRM 0.025 30GM
| NDC | Mfr | Size | Str | Form |
|---|---|---|---|---|
| 45802-0004-03 | PADAGIS | 28 | 2.5% | CREAM |
Generic Name
Substance Name
Product Type
Route
Application Number
Description
DESCRIPTION Each gram of Hydrocortisone Cream USP, 2.5% contains 25 mg of hydrocortisone in a cream base of cetyl alcohol, methylparaben, propylene glycol, propylparaben, purified water, sodium lauryl sulfate, and stearyl alcohol. Each gram of Hydrocortisone Ointment USP, 2.5% contains 25 mg of hydrocortisone in ointment base of light mineral oil and white petrolatum. Chemically, hydrocortisone is [Pregn-4-ene-3,20-dione,11,17,21-trihydroxy-, (11β)-] with the molecular formula (C 21 H 3O 0 5 ) and is represented by the following structural formula: Its molecular weight is 362.47 and its CAS Registery Number is 50-23-7. The topical corticosteroids, including hydrocortisone, constitute a class of primarily synthetic steroids used as anti-inflammatory and antipruritic agents. MM1
How Supplied
HOW SUPPLIED Hydrocortisone Cream USP, 2.5% is available as follows: 20 g tube (NDC 45802- 004 -02) 1 oz. (28 g) tube (NDC 45802- 004 -03) Hydrocortisone Ointment USP, 2.5% is available as follows: 20 g tube (NDC 45802- 014 -02) 1 lb. jar (NDC 45802- 014 -05)
Indications & Usage
INDICATIONS & USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis.
Dosage and Administration
DOSAGE & ADMINISTRATION Topical corticosteroids are generally applied to the affected area as a thin film from two to four times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.